β-oxidation of simvastatin in mouse liver preparations

Drug Metabolism and Disposition

Volumn 29, Issue 10, 2001, Pages 1251-1255

  Prueksaritanont, Thomayant ^a   Ma, Bennett ^a   Fang, Xiaojun ^a   Subramanian, Raju ^a   Yu, Jian ^a   Lin, Jiunn H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PRAVASTATIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIMVASTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG OXIDATION; FATTY ACID OXIDATION; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STEREOSPECIFICITY; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; COENZYME A; LIVER; MALE; MASS SPECTROMETRY; MICE; NAD; OXIDATION-REDUCTION; SIMVASTATIN;

EID: 0034837905     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pravastatin sodium (CS-514), a novel cholesterol-lowering agent which inhibits HMG-CoA reductase
2. Metabolism and excretion of atorvastatin in rats and dogs
3. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin
4. Biotransformation of cerivastatin in mice, rats and dogs in vivo
5. Metabolic disposition of simvastatin in patients with T-tube drainage
6. Biotransformation of fluvastatin sodium in humans
7. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation
8. Physiological disposition of HMG-CoA-reductase inhibitors
9. Biotransformation of pravastatin sodium in humans
10. Biotransformation of lovastatin V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human
11. 14C]-atorvastatin in patients with T-tube drainage
12. Protein measurement with the Folin phenol reagent
13. Clinical pharmacokinetics and practical applications of simvastatin
14. Oxidation of fatty acids
15. In vitro metabolism of simvastatin in humans: Identification of metabolizing enzymes and effect of the drug on hepatic P450s
16. 13C assignments of coenzyme B12 through the use of new two-dimensional NMR experiments
17. Metabolic disposition studies of simvastatin, a cholesterol-lowering prodrug
18. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG-CoA reductase
19. Long-chain acyl-CoA hydrolase from rat brain cytosol: Purification, characterization and immunohistochemical localization